← Open Payments lookup

MEAGAN MCFARLAND: Open Payments

NPI 1609155548 · SALEM, OR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$989 in 39 payments from 20 companies in 2025. Trend: 2023 $96 · 2024 $1,338 · 2025 $989

Food & beverage: $989
CompanyPaymentsAmount
Janssen Biotech, Inc.6$243
AstraZeneca Pharmaceuticals LP4$85
Merck Sharp & Dohme LLC3$68
PFIZER INC.3$62
Exelixis Inc.2$57
GENZYME CORPORATION2$50
ABBVIE INC.2$46
E.R. Squibb & Sons, L.L.C.2$45
TerSera Therapeutics LLC2$45
Agios Pharmaceuticals, Inc.1$40

Products named: RYBREVANT, KEYTRUDA, TALVEY, CABOMETYX, SARCLISA, VENCLEXTA, IBRANCE, Xermelo.

Industry payments across OR — which companies pay providers there.